atazanavir

(redirected from Reyataz)
Also found in: Medical.
Related to Reyataz: ritonavir
Translations

atazanavir

n atazanavir m
References in periodicals archive ?
La farmaceutica estadounidense es conocida por el antirretroviral Reyataz utilizado contra el VIH, por la ampicilina Pentrexyl recetada para tratar las infecciones de bacterias en vias respiratorias, urinarias y gastrointestinales y por el programa ImmunoScience, que investiga un grupo de enfermedades relacionadas con la inmunidad, entre ellas, la artritis reumatoide.
The exclusive launch of our generic version of Reyataz marks our fifth generic product offering for the treatment of HIV-1 infection, said Brendan OGrady, Executive Vice President, North America Commercial at Teva.
The team, led by Atlanta physician Melanie Thompson, recommends a regimen of Truvada or Epizom plus either Sustiva, Reyataz, Prezista, or Isentress.
At this time, I am taking the medications Reyataz, Combivir, and Norvir.
Its pharmaceutical product offerings include cardiovascular agents, such as Plavix, Pravachol, and Coumadin; virology products Reyataz, Sustiva, and Baraclude; oncology products Erbitux, Taxol, Sprycel, and lxempra; affective and other psychiatric disorder products, such as Abilify; and immunoscience products such as Orencia, among others.
89 Two Reyataz (150 mg each) once per ritonavir (Norvir) day, one Norvir (100 mg) per day, emtricitabine/tenofovir plus one Truvada (200 mg (Truvada) emtricitabine/300 mg tenofovir) per day atazanavir (Reyataz) $64.
A new study has found that if Reyataz (atazanavir), whether taken with or without ritonavir, is used with Prilosec (omeprazole, a proton-pump inhibitor used to reduce stomach acidity, for treating acid-reflux disease or other conditions), the blood level of atazanavir is reduced by three quarters or more, probably making it ineffective and leading to viral resistance.
One event, for example, focused on an unprecedented 15-0 drug approval for Reyataz by the Federal Drug Administration (fda.
HIV franchises for Sustiva and Reyataz were down 21% and 24% to $246 million and $206 million, respectively, and hepatitis B drug Baraclude sales were down 4% to $296 million.
MPP had earlier signed a deal with Bristol-Myers for generic versions of its HIV treatment Reyataz.
The company said Evotaz is coformulated to be one pill, once-daily, combining the protease inhibitor atazanavir, which is marketed as Reyataz (atazanavir 200 mg/300 mg) capsules, and cobicistat, a pharmacokinetic enhancer marketed by Gilead Sciences.
Sales were led by double-digit jumps in sales for Plavix and HIV treatments Reyataz and Sustiva.